These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 9737804)

  • 21. Changes in the use of analogue insulins in 37 206 children and adolescents with type 1 diabetes in 275 German and Austrian centers during the last twelve years.
    Kapellen TM; Wolf J; Rosenbauer J; Stachow R; Ziegler R; Szczepanski R; Holl RW;
    Exp Clin Endocrinol Diabetes; 2009 Jul; 117(7):329-35. PubMed ID: 19301233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes.
    Guevara-Aguirre J; Guevara-Aguirre M; Saavedra J; Bernstein G; Rosenbloom AL
    Diabetes Technol Ther; 2007 Aug; 9(4):372-6. PubMed ID: 17705693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.
    Becker RH; Frick AD; Nosek L; Heinemann L; Rave K
    Diabetes Care; 2007 Oct; 30(10):2506-7. PubMed ID: 17675541
    [No Abstract]   [Full Text] [Related]  

  • 24. Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus.
    Abalı S; Turan S; Atay Z; Güran T; Haliloğlu B; Bereket A
    Pediatr Diabetes; 2015 Aug; 16(5):361-6. PubMed ID: 25039448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in insulin therapy regimens over 10 yr in children and adolescents with type 1 diabetes attending diabetes camps.
    Redon I; Beltrand J; Martin D; Taupin P; Choleau C; Morandini M; Cahané M; Robert JJ;
    Pediatr Diabetes; 2014 Aug; 15(5):329-35. PubMed ID: 24016246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin doses in children using conventional therapy for insulin dependent diabetes.
    Kerouz N; el-Hayek R; Langhough R; MacDonald MJ
    Diabetes Res Clin Pract; 1995 Aug; 29(2):113-20. PubMed ID: 8591698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
    Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabolic control in children and adolescents with diabetes mellitus type I in Berne: a cross-sectional study].
    Flück CE; Kuhlmann BV; Mullis PE
    Schweiz Med Wochenschr; 1999 Nov; 129(44):1650-5. PubMed ID: 10588023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII.
    Anderson DG
    Pediatr Diabetes; 2009 Aug; 10(5):304-9. PubMed ID: 19076301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
    Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.
    Teló GH; Dougher CE; Volkening LK; Katz ML; Laffel LM
    Diabet Med; 2018 Oct; 35(10):1355-1363. PubMed ID: 29855077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 1 diabetes during adolescence: International comparison between Germany, Austria, and Sweden.
    Hanberger L; Samuelsson U; Holl RW; Fröhlich-Reiterer E; Åkesson K; Hofer S
    Pediatr Diabetes; 2018 May; 19(3):506-511. PubMed ID: 28940551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life among Norwegian children and adolescents with type 1 diabetes on intensive insulin treatment: a population-based study.
    Frøisland DH; Graue M; Markestad T; Skrivarhaug T; Wentzel-Larsen T; Dahl-Jørgensen K
    Acta Paediatr; 2013 Sep; 102(9):889-95. PubMed ID: 23738648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract]   [Full Text] [Related]  

  • 39. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.
    Alemzadeh R; Berhe T; Wyatt DT
    Pediatrics; 2005 May; 115(5):1320-4. PubMed ID: 15867042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achievement of metabolic control goals set by the American Diabetes Association and the International Society for Pediatric and Adolescent Diabetes in pediatric patients with type 1 diabetes from Spain.
    Enes P; Martín-Frías M; Álvarez MÁ; Yelmo R; Alonso M; Barrio R
    Diabetes Res Clin Pract; 2015 Feb; 107(2):300-5. PubMed ID: 25595220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.